Clinical Trial Update: Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the efficacy and safety of nemolizumab in adults with moderate-to-severe atopic dermatitis have been posted after completion of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Nemolizumab (nemolizumab)

Snippet

Sponsor: Galderma R&D | Conditions: Moderate-to-Severe Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2024-08-14